The COVID-19 pandemic is ravaging the world in so many ways. It has affected and hit hard how clinical trials were done and managed in pre-COVID times. While the direct impact is definitely on patient recruitment and patient care, other areas like data collection, data safety, data analysis, and overall trial management are hugely impacted.
Subscribe to the Cloudbyz Insight newsletter and be in the know.
A virtual clinical trial, also known as a decentralized clinical trial, is comparatively a new method of conducting clinical trials virtually. In a true sense, a virtual clinical trial has no physical interaction during the entire process. Technology plays a major role in a virtual clinical trial. Different patient-facing technologies like wearables, electronic monitoring apps, online social engagement
The clinical research industry has been rapidly remodeled by the digital revolution.
This paradigm shift is exploding into a new way of drug development and clinical trials. A way where patient experience is at utmost precedence.
Revolving business models, services, and products around the patient is becoming the new normal.
As the spread of COVID-19 has affected every industry, pharmaceutical and biotech companies are feeling the heat of it. In our last piece, we covered some of the issues the clinical trial industry, as a whole, was facing. With unexpected delays, over-flooded inboxes, and patient safety at risk, here are specific ways sponsors can and are alleviating the negative impact of the virus…
A virtual clinical trial, also known as a decentralized clinical trial, is comparatively a new method of conducting clinical trials virtually. In a true sense, a virtual clinical trial has no physical interaction during the entire process. Technology plays a major role in a virtual clinical trial. Different patient-facing technologies like wearables, electronic monitoring apps, online social engagement
The clinical research industry has been rapidly remodeled by the digital revolution.
This paradigm shift is exploding into a new way of drug development and clinical trials. A way where patient experience is at utmost precedence.
Revolving business models, services, and products around the patient is becoming the new normal.
As the spread of COVID-19 has affected every industry, pharmaceutical and biotech companies are feeling the heat of it. In our last piece, we covered some of the issues the clinical trial industry, as a whole, was facing. With unexpected delays, over-flooded inboxes, and patient safety at risk, here are specific ways sponsors can and are alleviating the negative impact of the virus…
Cloudbyz is focused on building innovative enterprise applications and solutions natively on cloud to help enterprises to be innovative and agile.
Quicklinks
Popular Posts
Social media